Acetylcholinesterase inhibitor treatment alleviated cognitive impairment caused by delayed encephalopathy due to carbon monoxide poisoning: Two case reports and a review of the literature. | Canada Hyperbarics Skip to main content
Case Study Medicine 2017

Acetylcholinesterase inhibitor treatment alleviated cognitive impairment caused by delayed encephalopathy due to carbon monoxide poisoning: Two case reports and a review of the literature.

Yanagiha K, Ishii K, Tamaoka A — Medicine, 2017

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reported two cases of delayed encephalopathy due to carbon monoxide poisoning and reviewed existing literature to assess the effectiveness of acetylcholinesterase inhibitor treatment.

What They Found

In two women (aged 69 and 60) with delayed encephalopathy after carbon monoxide poisoning, acetylcholinesterase inhibitor (AchEI) treatment significantly improved cognitive function. Case 1's Mini-Mental State Examination score improved from 9 to 28 points, and Case 2's Hasegawa's dementia rating scale score improved from 4 to 25 points after AchEI administration.

What This Means for Canadian Patients

For Canadian patients experiencing cognitive impairment from delayed encephalopathy due to carbon monoxide poisoning, acetylcholinesterase inhibitors could be a beneficial treatment option. This approach may offer an alternative when conventional therapies like hyperbaric oxygen therapy are insufficient.

Canadian Relevance

This study has no direct Canadian connection as it was not conducted in Canada, nor does it involve Canadian researchers or patients.

Study Limitations

As a case report, this study's findings are limited by its small sample size of only two patients, preventing generalization to a broader population.

Was this summary helpful?

Study Details

Study Type Case Study
Category Carbon Monoxide Poisoning
Source Pubmed
PubMed ID 28225493
Year Published 2017
Journal Medicine
MeSH Terms Aged; Brain Diseases; Carbon Monoxide Poisoning; Cholinesterase Inhibitors; Cognitive Dysfunction; Female; Humans; Middle Aged; Nootropic Agents

Cite This Study

Share

Find a Canadian Clinic Treating Carbon Monoxide Poisoning

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.